openPR Logo
Press release

Adrenal Crisis Market Sees Swift Expansion Throughout Forecast Period (2023-2032), Analyzed by DelveInsight | Featuring Takeda Pharma, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, and Antares Pharma

02-23-2024 05:20 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Adrenal Crisis Market

Adrenal Crisis Market

DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Adrenal crisis Market Report:
• The Adrenal crisis market size was valued approximately USD 11.5 Million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In 7MM nations, there were 130,175 prevalent instances of adrenal crisis in 2021
• Acute life-threatening conditions like adrenal crisis, also known as acute adrenal insufficiency and Addisonian crisis, continue to be a major cause of death in people with adrenal insufficiency
• Elshimy et al. (2021) describe an increase in the reported prevalence of adrenal insufficiency in Europe over time
• According to Miller et al. (2020), adrenal insufficiency (AI), which is characterised by an annual estimated incidence of adrenal crisis of 5-10 episodes per 100 patient-years, is a substantial source of morbidity and mortality in children.
• Key Adrenal crisis Companies: Takeda Pharmaceutical, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma, Mallinckrodt Pharmaceutical, Mylan Pharmaceutical, AG eTon Pharmaceuticals, and others
• Key Adrenal crisis Therapies: ATRS-1902, and others
• The Adrenal crisis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Adrenal crisis pipeline products will significantly revolutionize the Adrenal crisis market dynamics.

Adrenal crisis Overview
Acute life-threatening conditions such as adrenal crisis, also known as acute adrenal insufficiency and Addisonian crisis, continue to be a major cause of death in people with adrenal insufficiency.

Get a Free sample for the Adrenal crisis Market Report
https://www.delveinsight.com/report-store/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Adrenal crisis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Adrenal crisis Epidemiology Segmentation:
The Adrenal crisis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Adrenal crisis
• Prevalent Cases of Adrenal crisis by severity
• Gender-specific Prevalence of Adrenal crisis
• Diagnosed Cases of Episodic and Chronic Adrenal crisis

Download the report to understand which factors are driving Adrenal crisis epidemiology trends @ Adrenal crisis Epidemiology Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Adrenal crisis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Adrenal crisis market or expected to get launched during the study period. The analysis covers Adrenal crisis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Adrenal crisis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Adrenal crisis Therapies and Key Companies
• ATRS-1902: Antares Pharma

Discover more about therapies set to grab major Adrenal crisis market share @ Adrenal crisis Treatment Market
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Adrenal crisis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Adrenal crisis Companies: Takeda Pharmaceutical, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma, Mallinckrodt Pharmaceutical, Mylan Pharmaceutical, AG eTon Pharmaceuticals, and others
• Key Adrenal crisis Therapies: ATRS-1902, and others
• Adrenal crisis Therapeutic Assessment: Adrenal crisis current marketed and Adrenal crisis emerging therapies
• Adrenal crisis Market Dynamics: Adrenal crisis market drivers and Adrenal crisis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Adrenal crisis Unmet Needs, KOL's views, Analyst's views, Adrenal crisis Market Access and Reimbursement

To know more about Adrenal crisis companies working in the treatment market, visit @ Adrenal crisis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Adrenal crisis Market Report Introduction
2. Executive Summary for Adrenal crisis
3. SWOT analysis of Adrenal crisis
4. Adrenal crisis Patient Share (%) Overview at a Glance
5. Adrenal crisis Market Overview at a Glance
6. Adrenal crisis Disease Background and Overview
7. Adrenal crisis Epidemiology and Patient Population
8. Country-Specific Patient Population of Adrenal crisis
9. Adrenal crisis Current Treatment and Medical Practices
10. Adrenal crisis Unmet Needs
11. Adrenal crisis Emerging Therapies
12. Adrenal crisis Market Outlook
13. Country-Wise Adrenal crisis Market Analysis (2019-2032)
14. Adrenal crisis Market Access and Reimbursement of Therapies
15. Adrenal crisis Market Drivers
16. Adrenal crisis Market Barriers
17. Adrenal crisis Appendix
18. Adrenal crisis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Adrenal crisis Epidemiology https://www.delveinsight.com/report-store/adrenal-crisis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

DelveInsight's 'Adrenal crisis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Adrenal crisis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Brain/cranial Implants Market: https://www.delveinsight.com/report-store/brain-implants-market-market
• Ambulatory Arrhythmia Monitoring Devices Market: https://www.delveinsight.com/report-store/ambulatory-arrhythmia-monitoring-devices-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/growth-hormone-deficiency-ghd-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Hiatal Hernia Market: https://www.delveinsight.com/sample-request/hiatal-hernia-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/blog/cardiac-rhythm-management-devices-market-outlook
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/blog/tag/blood-glucose-monitoring-systems-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Bronchial Spasm Market: https://www.delveinsight.com/report-store/bronchial-spasm-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market

Contact Us:
Ankit Nigam
Assistant Manager Marketing
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adrenal Crisis Market Sees Swift Expansion Throughout Forecast Period (2023-2032), Analyzed by DelveInsight | Featuring Takeda Pharma, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, and Antares Pharma here

News-ID: 3396132 • Views:

More Releases from DelveInsight Business Research

Triple Negative Breast Cancer Market Forecast 2034 - FDA Approvals, Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight
Triple Negative Breast Cancer Market Forecast 2034 - FDA Approvals, Clinical Tri …
DelveInsight's "Triple Negative Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Triple Negative Breast Cancer, historical and forecasted epidemiology as well as the Triple Negative Breast Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Triple Negative Breast Cancer market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and
Relapsed/Refractory Multiple Myeloma Clinical Trial Pipeline Expands as 55+ Companies Driving Innovation in Relapsed/Refractory Multiple Myeloma Therapeutics | DelveInsight
Relapsed/Refractory Multiple Myeloma Clinical Trial Pipeline Expands as 55+ Comp …
DelveInsight's, "Relapsed/Refractory Multiple Myeloma Pipeline Insight, 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Relapsed/Refractory Multiple Myeloma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. DelveInsight's report, "Relapsing Refractory Multiple Myeloma Pipeline Insight 2025,"
PD-L1 Inhibitors Market Set for Robust Growth Across 7MM, Driven by Novel Immunotherapies, Combination Strategies, and Expanding Indications | DelveInsight
PD-L1 Inhibitors Market Set for Robust Growth Across 7MM, Driven by Novel Immuno …
The global PD-L1 inhibitors market is poised for substantial growth over the next decade, reflecting the transformative impact of immunotherapy on cancer treatment. In 2023, the PD-L1 inhibitors market across the seven major markets (7MM) reached approximately USD 36 billion, with the United States accounting for the largest share. According to DelveInsight's latest report, "PD-L1 Inhibitors Market Insight, Epidemiology and Market Forecast - 2034", the PD-L1 inhibitors market in the seven
BCL-2 Inhibitors Market Poised for Transformative Growth Driven by Next-Generation Oncology Therapies and Expanding Clinical Pipeline | DelveInsight
BCL-2 Inhibitors Market Poised for Transformative Growth Driven by Next-Generati …
(Albany, USA) - The BCL-2 inhibitors market is on the cusp of remarkable expansion over the next decade, propelled by increasing cancer incidence, growing awareness of apoptosis-targeting therapies, and the rapid evolution of clinical research in hematologic malignancies. According to DelveInsight's latest market report, "B-Cell Leukemia/Lymphoma-2 (BCL-2) Inhibitors Market Size, Epidemiology, Competitive Landscape, and Market Forecast - 2034," the global market is expected to experience substantial growth across the United

All 5 Releases


More Releases for Adrenal

Rising Cigarette Smoking Boost The Adrenal Cancer: Key Factor Driving The Growth …
The Adrenal Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Adrenal Cancer Diagnostics Market Size During the Forecast Period? Over the past few years, the market size for adrenal cancer diagnostics has been experiencing strong growth. It is projected to
Congenital Adrenal Hyperplasia Treatment Market Report and Forecast 2024-2032
The congenital adrenal hyperplasia treatment market size was valued at USD 422.9 million in 2023, driven by increasing government funding and assistance along with joint research. The market size is anticipated to grow at a CAGR of 8.10% during the forecast period of 2024-2032 to achieve a value of USD 852.42 million by 2032. Congenital Adrenal Hyperplasia Treatment: Introduction Congenital Adrenal Hyperplasia (CAH) treatment typically involves lifelong replacement of deficient hormones. For
Addison's Disease Testing: Diagnostic Approaches for Unveiling Adrenal Insuffici …
Addison Disease Testing Market 2023 Forecast: Unveiling Opportunities and Growth Addison Disease Testing Market research report helps to recognize the market challenges and opportunities. Global Addison Disease Testing Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including
Pheochromocytoma Market - Pheochromocytoma: Advancements in Diagnosis and Treatm …
Newark, New Castle, USA: The "Pheochromocytoma Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Pheochromocytoma Market: https://www.growthplusreports.com/report/pheochromocytoma-market/8764 This latest report researches the industry structure, sales, revenue, price and
Adrenal Insufficiency Market to Witness Growth by 2032, estimates DelveInsight
DelveInsight's "Adrenal Insufficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adrenal Insufficiency, historical and forecasted epidemiology as well as the Adrenal Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Adrenal Insufficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Adrenal Insufficiency market size
Global Adrenocortical Carcinoma (Adrenal Cortex Cancer) Market, H1, 2017 :Market …
"The Report Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" GlobalData's clinical trial report, Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017" provides an overview of Adrenocortical Carcinoma (Adrenal Cortex Cancer) clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenocortical Carcinoma